Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial
Male
Clinical Trials as Topic
Patient Dropouts
Professional-Patient Relations
16. Peace & justice
03 medical and health sciences
0302 clinical medicine
Professional-Family Relations
Myopia
Humans
Multicenter Studies as Topic
Family
Female
Child
Randomized Controlled Trials as Topic
DOI:
10.1191/1740774505cn113oa
Publication Date:
2005-10-19T21:02:11Z
AUTHORS (8)
ABSTRACT
Background The Correction of Myopia Evaluation Trial (COMET), a randomized, multicenter clinical trial myopia progression in children, had an exceptionally high retention rate 98.5% (462/469) at three years follow-up. present investigation was designed to evaluate and compare the reasons for COMET's according participating families center staff. Methods Families ( n = 411) staff 35) completed confidential 19-item questionnaire by indicating families' levels preference each item, rating its importance keeping study. evaluated study features four categories: characteristics, operational aspects, specific elements, incentives. Results showed that most viewed very favorably. Features appealed 90% or more promoted continued participation included attributes such as friendliness, responsiveness encouragement, aspects pertaining standard care completeness eye exam, quality free eyeglasses. Compared families, tended underestimate following retention: seeing same visit, appointment reminders, location, newsletters, commitment study, being part nationwide length association with college optometry, drops p < 0.05 chi-square analyses). However, responses also revealed less preferred components protocol (e.g., drops), which might have been reluctant respond unfavorably. Conclusions Our findings highlight intangible factors participants' maintaining rates, usefulness surveying both
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (14)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....